Dagon Pharmaceuticals Private Limited, a active private limited company, was established on 02 April 1993 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1993PTC019247. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.25 Cr.
It upholds a compliant status. Its leadership includes Bhupatbhai Mahidasbhai Bhut (Director), Gautam Ishwarbhai Bhut (Whole-Time Director), Kishorbhai Mahidas Bhut (Whole-Time Director). Past directors included Gautam Ishwarbhai Bhut, Kishorbhai Mahidas Bhut. It holds ₹17.06 Cr open charges and ₹4.45 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 211,Silver Coin, Shrenik Park Char Rasta, Productivity Road, Akota, Vadodara, Gujarat, 390020.
U24231GJ1993PTC019247
019247
02 April 1993
₹2.50 Cr
₹2.25 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Dagon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhupatbhai Mahidasbhai Bhut | Director | 02 Feb 2005 | Current |
| Gautam Ishwarbhai Bhut | Whole-Time Director | 24 Mar 2001 | Current |
| Kishorbhai Mahidas Bhut | Whole-Time Director | 02 Apr 1993 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dagon Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 15.94% decrease. The company also saw a substantial improvement in profitability, with a 42.67% increase in profit. The company's net worth moved up by a moderate rise of 9.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Dagon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹170,635,250.00
₹44,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2024 | Sidbi | ₹9.30 M | Open |
| 26 Jul 2024 | Sidbi | ₹1.12 Cr | Open |
| 02 Mar 2022 | Sidbi | ₹1.23 Cr | Open |
| 23 Jun 2021 | Sidbi | ₹9.90 M | Open |
| 11 Jun 2020 | Sidbi | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dagon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dagon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dagon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dagon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Dagon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
A charge with Sidbi amounted to Rs. 0.93 Cr with Charge ID 100955452 was registered on 26 Jul 2024. was recorded as a recent event.
The activity A charge with Sidbi amounted to Rs. 1.12 Cr with Charge ID 100955450 was registered on 26 Jul 2024. was completed.
A charge with Sidbi amounted to Rs. 1.23 Cr with Charge ID 100544669 was registered on 02 Mar 2022. was recorded as a recent event.
A charge with Sidbi amounted to Rs. 0.99 Cr with Charge ID 100463503 was registered on 23 Jun 2021. was recorded as a recent event.
The CIN of Dagon Pharmaceuticals Private Limited is U24231GJ1993PTC019247.
Dagon Pharmaceuticals Private Limited is headquartered at 211,Silver Coin, Shrenik Park Char Rasta, Productivity Road, Akota, Vadodara, Gujarat, 390020.
Dagon Pharmaceuticals Private Limited was incorporated on 02 April 1993.
The current directors of Dagon Pharmaceuticals Private Limited are
The primary industry of Dagon Pharmaceuticals Private Limited is Manufacturing.
Dagon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dagon Pharmaceuticals Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.25 Cr.
The compliance status of Dagon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX